My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Enlivex Therapeutics Ltd. - Ordinary Shares (NQ:ENLV)

1.295 +0.398 (+44.40%)

Streaming Delayed Price Updated: 11:53 AM EST, Nov 24, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Enlivex Therapeutics Ltd. - Ordinary Shares

< Previous 1 2 3 Next >

The market is filled with gapping stocks in Monday's session. ↗

Today 10:30 EST

In today's session, there are notable price gaps in the US markets on Monday. Take a closer look at the stocks that are gap up and gap down.

Via Chartmill

ENLV Stock Surges After Pivot To Crypto-Backed Treasury, Names Former Italian PM To Board ↗

Today 9:45 EST

RAIN token price nearly doubled, with retail sentiment on Stocktwits trending ‘bullish’ and chatter at ‘high’ levels.

Via Stocktwits

Topics ETFs

Wondering what's happening in today's pre-market session? ↗

Today 8:30 EST

Let's have a look at what is happening on the US markets before the opening bell on Monday. Below you can find the top gainers and losers in today's pre-market session.

Via Chartmill

What's going on in today's session ↗

August 18, 2025

Intrigued by the market activity one hour before the close of the markets on Monday? Uncover the key winners and losers of today's session in our insightful analysis.

Via Chartmill

12 Health Care Stocks Moving In Monday's Intraday Session ↗

August 18, 2025

Via Benzinga

Monday's session: top gainers and losers ↗

August 18, 2025

Curious to know what's happening on the US markets in the middle of the day on Monday? Join us as we explore the top gainers and losers in today's session.

Via Chartmill

Let's uncover which stocks are experiencing notable gaps during today's session. ↗

August 18, 2025

Let's have a look at the gap up and gap down stocks in today's session.

Via Chartmill

Which stocks have an unusual volume on Tuesday? ↗

March 04, 2025

The trading volume of these stocks is deviating from the norm in today's session.

Via Chartmill

Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

April 29, 2024

Via Benzinga

Tesla To $180? Here Are 10 Top Analyst Forecasts For Friday ↗

April 12, 2024

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Via Benzinga

Nasdaq Jumps 250 Points; Crude Oil Down 1% ↗

April 11, 2024

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite surging more than 250 points on Thursday. The Dow traded up 0.18% to 38,532.50 while the NASDAQ rose 1.63% to 16,433.83....

Via Benzinga

Topics Stocks

Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

April 11, 2024

Shares of Fastenal Company (NASDAQ: FAST) fell sharply during Thursday’s session following worse-than-expected first-quarter financial results.

Via Benzinga

Dow Dips 100 Points; CarMax Earnings Miss Views ↗

April 11, 2024

U.S. stocks traded mixed midway through trading, with the Dow Jones index falling around 100 points on Thursday.

Via Benzinga

Topics Earnings Stocks

Nasdaq Gains Over 50 Points; US Producer Prices Increase In March ↗

April 11, 2024

U.S. stocks traded mostly higher this morning, following the release of PPI data. Following the market opening Thursday, the Dow traded up 0.03% to 38,472.80 while the NASDAQ rose 0.40% to 16,234.94....

Via Benzinga

Topics Stocks

ENLV Stock Earnings: Enlivex Therapeutics Misses EPS for Q4 2023 ↗

April 05, 2024

ENLV stock results show that Enlivex Therapeutics missed analyst estimates for earnings per share the fourth quarter of 2023.

Via InvestorPlace

This Biotech Is Bringing Balance To The Body – How Homeostasis Is Critical To Fighting Everything From Sepsis To Cancer ↗

June 16, 2023

Oren Hershkovitz, Ph.D., CEO of Enlivex Therapeutics Ltd. (NASDAQ: ENLV) was recently a guest on Benzinga’s All-Access.

Via Benzinga

Analysts At H.C. Wainwright & Co. Set 12-Month Target Of $15 Per Share For ENLV Thanks To High Profile Collaboration Agreement, Multiple Ongoing Clinical Trials ↗

April 13, 2023

This month, H.C. Wainwright & Co.

Via Benzinga

Why RayzeBio Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

December 26, 2023

Shares of RayzeBio, Inc. (NASDAQ: RYZB) rose sharply during Tuesday’s session after the company announced that it will be acquired by Bristol Myers Squibb for $62.50 per share in cash in a deal worth...

Via Benzinga

Enlivex, Beigene Collaborate To Test A New Combination Treatment To Fight Advanced-Stage Solid Tumors ↗

April 11, 2023

This month, Enlivex Therapeutics Ltd.

Via Benzinga

Why Pioneer Natural Resources Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket ↗

April 10, 2023

Gainers PLx Pharma Inc. (NASDAQ: PLXP) jumped 149.6% to $0.2623 in pre-market trading after dropping over 13% on Thursday.

Via Benzinga

Why AAR Shares Are Trading Lower By 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

December 22, 2023

Shares of AAR Corp. (NYSE: AIR) fell during Friday’s session after the company reported mixed second-quarter financial results.

Via Benzinga

A Novel Immunotherapy That Could Bring Hope To Millions Of Sepsis Patients Received MultiCountry Clearance For Expanded Clinical Trial

December 07, 2022

By Rachael Green, Benzinga

Via News Direct

What's Next For Cell Therapy In Oncology? Enlivex (NASDAQ: ENLV) Says It Has The Answers

December 06, 2022

By Ernest Dela Aglanu, Benzinga

Via News Direct

Why Fortinet Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

November 03, 2023

Gainers Benson Hill, Inc. (NYSE: BHIL) shares jumped 48.1% to $0.3740.

Via Benzinga

First Patients Dosed in Phase I/II Trial of Enlivex’s Off-the-Shelf Cell Therapy Candidate, AllocetraTM

December 02, 2022

By Rachael Green, Benzinga

Via News Direct

Israeli Ministry Of Health Clears Way For Human Trials Of AllocetraTM, A Proprietary Off-the-Shelf Immunotherapy For Solid Tumors

December 01, 2022

By Rachael Green, Benzinga

Via News Direct

FDA Clears Enlivex Therapeutics' IND Application To Study Allocetra™ in Patients with Advanced Solid Malignancies ↗

November 29, 2022

Enlivex Therapeutics Ltd. (NASDAQ: ENLV) announced that the U.S. Food & Drug Administration (FDA) had cleared an Investigational New Drug (IND) application to study Allocetra™ in patients with...

Via Benzinga

First Patients Dosed in Phase I/II Trial of Enlivex's Off-the-Shelf Cell Therapy Candidate, AllocetraTM ↗

November 22, 2022

On November 13, Enlivex (NASDAQ: ENLV) announced that the first patient has been dose

Via Benzinga

Enlivex Doses First Patient in Phase I/II Trial to Evaluate Allocetra™ for Advanced Solid Tumor Treatment ↗

November 15, 2022

Enlivex Therapeutics Ltd.

Via Benzinga

Enlivex: Meet The Company Championing A Paradigm Shift In Cancer Treatment ↗

November 15, 2022

Via Benzinga

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.